Usefulness of continuous electrocardiographic monitoring for atrial fibrillation

A. John Camm, Giorgio Corbucci, Luigi Padeletti

Research output: Contribution to journalArticle

Abstract

The problem of early recognition of atrial fibrillation (AF) is greatly aggravated by the often silent nature of the rhythm disturbance. In about 1/3 of patients with this arrhythmia, patients are not aware of the so-called asymptomatic AF. In the past 15 years, the diagnostic data provided by implanted pacemakers and defibrillators have dramatically increased knowledge about silent AF. The unreliability of symptoms to estimate AF burden and to identify patients with and without AF has been pointed out not only by pacemaker trials but also in patients without implanted devices. The technology for continuous monitoring of AF has been largely validated. It is a powerful tool to detect silent paroxysmal AF in patients without previously documented arrhythmic episodes, such as those with cryptogenic stroke or other risk factors. Early diagnosis triggers earlier treatment for primary or secondary stroke prevention. Today, new devices are also available for pure electrocardiographic monitoring, implanted subcutaneously using a minimally invasive technique. In conclusion, this recent and promising technology adds relevant clinical and scientific information to improve risk stratification for stroke and may play an important role in testing and tailoring the therapies for rhythm and rate control.

Original languageEnglish
Pages (from-to)270-276
Number of pages7
JournalThe American Journal of Cardiology
Volume110
Issue number2
DOIs
Publication statusPublished - Jul 15 2012

Fingerprint

Atrial Fibrillation
Stroke
Technology
Equipment and Supplies
Defibrillators
Secondary Prevention
Cardiac Arrhythmias
Early Diagnosis
Therapeutics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Usefulness of continuous electrocardiographic monitoring for atrial fibrillation. / Camm, A. John; Corbucci, Giorgio; Padeletti, Luigi.

In: The American Journal of Cardiology, Vol. 110, No. 2, 15.07.2012, p. 270-276.

Research output: Contribution to journalArticle

Camm, A. John ; Corbucci, Giorgio ; Padeletti, Luigi. / Usefulness of continuous electrocardiographic monitoring for atrial fibrillation. In: The American Journal of Cardiology. 2012 ; Vol. 110, No. 2. pp. 270-276.
@article{94f4a8925ae940f3ad2fa4acbc8cf995,
title = "Usefulness of continuous electrocardiographic monitoring for atrial fibrillation",
abstract = "The problem of early recognition of atrial fibrillation (AF) is greatly aggravated by the often silent nature of the rhythm disturbance. In about 1/3 of patients with this arrhythmia, patients are not aware of the so-called asymptomatic AF. In the past 15 years, the diagnostic data provided by implanted pacemakers and defibrillators have dramatically increased knowledge about silent AF. The unreliability of symptoms to estimate AF burden and to identify patients with and without AF has been pointed out not only by pacemaker trials but also in patients without implanted devices. The technology for continuous monitoring of AF has been largely validated. It is a powerful tool to detect silent paroxysmal AF in patients without previously documented arrhythmic episodes, such as those with cryptogenic stroke or other risk factors. Early diagnosis triggers earlier treatment for primary or secondary stroke prevention. Today, new devices are also available for pure electrocardiographic monitoring, implanted subcutaneously using a minimally invasive technique. In conclusion, this recent and promising technology adds relevant clinical and scientific information to improve risk stratification for stroke and may play an important role in testing and tailoring the therapies for rhythm and rate control.",
author = "Camm, {A. John} and Giorgio Corbucci and Luigi Padeletti",
year = "2012",
month = "7",
day = "15",
doi = "10.1016/j.amjcard.2012.03.021",
language = "English",
volume = "110",
pages = "270--276",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Usefulness of continuous electrocardiographic monitoring for atrial fibrillation

AU - Camm, A. John

AU - Corbucci, Giorgio

AU - Padeletti, Luigi

PY - 2012/7/15

Y1 - 2012/7/15

N2 - The problem of early recognition of atrial fibrillation (AF) is greatly aggravated by the often silent nature of the rhythm disturbance. In about 1/3 of patients with this arrhythmia, patients are not aware of the so-called asymptomatic AF. In the past 15 years, the diagnostic data provided by implanted pacemakers and defibrillators have dramatically increased knowledge about silent AF. The unreliability of symptoms to estimate AF burden and to identify patients with and without AF has been pointed out not only by pacemaker trials but also in patients without implanted devices. The technology for continuous monitoring of AF has been largely validated. It is a powerful tool to detect silent paroxysmal AF in patients without previously documented arrhythmic episodes, such as those with cryptogenic stroke or other risk factors. Early diagnosis triggers earlier treatment for primary or secondary stroke prevention. Today, new devices are also available for pure electrocardiographic monitoring, implanted subcutaneously using a minimally invasive technique. In conclusion, this recent and promising technology adds relevant clinical and scientific information to improve risk stratification for stroke and may play an important role in testing and tailoring the therapies for rhythm and rate control.

AB - The problem of early recognition of atrial fibrillation (AF) is greatly aggravated by the often silent nature of the rhythm disturbance. In about 1/3 of patients with this arrhythmia, patients are not aware of the so-called asymptomatic AF. In the past 15 years, the diagnostic data provided by implanted pacemakers and defibrillators have dramatically increased knowledge about silent AF. The unreliability of symptoms to estimate AF burden and to identify patients with and without AF has been pointed out not only by pacemaker trials but also in patients without implanted devices. The technology for continuous monitoring of AF has been largely validated. It is a powerful tool to detect silent paroxysmal AF in patients without previously documented arrhythmic episodes, such as those with cryptogenic stroke or other risk factors. Early diagnosis triggers earlier treatment for primary or secondary stroke prevention. Today, new devices are also available for pure electrocardiographic monitoring, implanted subcutaneously using a minimally invasive technique. In conclusion, this recent and promising technology adds relevant clinical and scientific information to improve risk stratification for stroke and may play an important role in testing and tailoring the therapies for rhythm and rate control.

UR - http://www.scopus.com/inward/record.url?scp=84862761618&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862761618&partnerID=8YFLogxK

U2 - 10.1016/j.amjcard.2012.03.021

DO - 10.1016/j.amjcard.2012.03.021

M3 - Article

C2 - 22503584

AN - SCOPUS:84862761618

VL - 110

SP - 270

EP - 276

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 2

ER -